The release of BIO gives the public the opportunity to exchange ETH or other DeSci tokens for $BIO tokens before the BIO protocol goes live.
The BIO Association officially announced its community launch and fair launch today. The BIO Association is a Swiss non-profit organization founded by key members of VitaDAO, a decentralized science organization supported by Pfizer's venture capital arm and Balaji Srinivasan. The BIO Association aims to develop a decentralized biotechnology network and serve as a launch platform for on-chain scientific communities, connecting the fields of biotechnology and cryptocurrency. Currently, the BIO network consists of eight different scientific communities focused on areas such as longevity, women's health, neurodegenerative diseases, and synthetic biology.
The release of BIO gives the public the opportunity to exchange ETH or other DeSci tokens for $BIO tokens before the BIO protocol goes live.
Democratizing Scientific Research and Funding
BIO has the potential to revolutionize the biotechnology industry by democratizing scientific research and funding, utilizing DeSci and blockchain technology to create BioDAOs, which are community-owned organizations that collaborate globally to develop and fund scientific intellectual property. This approach breaks down traditional barriers in the biotechnology field, accelerates innovation, and allows researchers, patients, and enthusiasts from around the world to participate more transparently and equitably.
Fair Launch and Community Genesis Plan
In the spirit of early cryptocurrency launches like Ethereum, Solana, and Arweave, the BIO Association has chosen a fair and open launch method. This approach reflects the community's commitment to transparency and equal opportunity in the rapidly evolving DeSci field.
The BIO token empowers holders to filter new BioDAOs incubated within the future BIO network and gain whitelist access to funding for new research projects at top universities and researchers, allowing anyone to become an early beneficiary in the development of new drugs and products within the BIO network.
As interest in DeSci continues to grow, innovations within the BIO ecosystem are attracting funding at an increasingly rapid pace. Success stories include a new gene therapy targeting aging, VitaRNA, which saw its value rise by 150% in a single day after positive results in in vitro testing. Meanwhile, DeSci DAO tokens within the BIO ecosystem are also on the rise, such as HairDAO's HAIR token, which has grown over 10 times since its launch in 2023.
Genesis Token Holder List
The BIO Association has received support from numerous investors in the biotechnology, cryptocurrency, and venture capital sectors. After spinning off from Molecule AG, a Swiss company building tokenized infrastructure for DeSci organizations, the BIO genesis token holders include: ZeePrime Capital, Beaker DAO, Boost VC, 1kx, ID Theory, Compound, Cherry Crypto, L1D, Fifty Years, Northpond Ventures, KdT Ventures, Sora Ventures, and The LAO.
Innovative Launch Mechanism
The BIO Association has introduced an innovative fair launch mechanism, with the first auction held during the August bear market, successfully raising over $5 million. The mainnet launch is planned to take place on Ethereum, in line with other prominent DeSci projects.
Looking Ahead
In the coming weeks, the BIO Association will announce selected strategic participants to further solidify its position in the industry. These upcoming announcements will highlight the project's close ties to the biotechnology and cryptocurrency fields.
During the community genesis event of BIO, users can exchange ETH or DeSci DAO tokens within the BIO network for BIO tokens. The genesis event will last for 45 days or until the funding amount reaches a fully diluted valuation (FDV) cap of $100 million. After the event concludes, BIO tokens will be temporarily non-transferable until circulation rights are unlocked through community governance voting.
About the BIO Association
The BIO Association is a non-profit organization focused on developing the BIO protocol, an innovative protocol designed to guide capital and talent into the decentralized science (DeSci) field. The BIO protocol provides decentralized funding, liquidity, and incentive mechanisms for on-chain scientific communities (i.e., "BioDAOs"), promoting the advancement of preclinical research by combining DeFi technology with real-world IP intellectual property. Revenue from IP sales, licensing, and health products will cycle back into the network, providing ongoing funding support for the next generation of biomedical research and development. This decentralized model allows global researchers, supporters, and community enthusiasts to collaborate closely on scientific innovations, more efficiently translating biotechnology achievements into reality. BIO was founded by core members of VitaDAO, a decentralized science organization supported by Pfizer's venture capital and Balaji Srinivasan.
免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。
